Since MA3/DP4 TCR T cells are unable to directly recognize antigen-positive melanoma cells, an ability that is generally expected only for antitumor CD8 T cells, we analyzed a more typical CD4 T-cell response that is based on (cross-) presentation of tumor antigens by DC. The gene discussed is CD8A; the disease is melanoma.